WNT3A Gene

WNT3A Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">WNT3A Gene</th>
</tr>
<tr>
<td class="label">Receptor</td>
<td>Affinity</td>
</tr>
<tr>
<td class="label">FZD1</td>
<td>High</td>
</tr>
<tr>
<td class="label">FZD5</td>
<td>High</td>
</tr>
<tr>
<td class="label">FZD7</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">LRP6</td>
<td>Essential</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Level</td>
</tr>
<tr>
<td class="label">Dorsal neural tube</td>
<td>High</td>
</tr>
<tr>
<td class="label">Forebrain</td>
<td>High</td>
</tr>
<tr>
<td class="label">[Hippocampus](/brain-regions/hippocampus)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">[Cortex](/brain-regions/cortex)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Agent</td>
</tr>
<tr>
<td class="label">Protein delivery</td>
<td>Recombinant WNT3A</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-WNT3A</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>GSK3β inhibitors</td>
</tr>
<tr>
<td class="label">Receptor agonists</td>
<td>FZD agonists</td>
</tr>
</table>

Wnt3A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

WNT3A Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">WNT3A Gene</th>
</tr>
<tr>
<td class="label">Receptor</td>
<td>Affinity</td>
</tr>
<tr>
<td class="label">FZD1</td>
<td>High</td>
</tr>
<tr>
<td class="label">FZD5</td>
<td>High</td>
</tr>
<tr>
<td class="label">FZD7</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">LRP6</td>
<td>Essential</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Level</td>
</tr>
<tr>
<td class="label">Dorsal neural tube</td>
<td>High</td>
</tr>
<tr>
<td class="label">Forebrain</td>
<td>High</td>
</tr>
<tr>
<td class="label">[Hippocampus](/brain-regions/hippocampus)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">[Cortex](/brain-regions/cortex)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Agent</td>
</tr>
<tr>
<td class="label">Protein delivery</td>
<td>Recombinant WNT3A</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-WNT3A</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>GSK3β inhibitors</td>
</tr>
<tr>
<td class="label">Receptor agonists</td>
<td>FZD agonists</td>
</tr>
</table>

Wnt3A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
title: WNT3A Gene
.infobox.infix-gene
; Gene Symbol
: WNT3A
; Full Name
: WNT Family Member 3A
; Chromosomal Location
: 17q21.31
; NCBI Gene ID
: [89780](https://www.ncbi.nlm.nih.gov/gene/89780)
; OMIM
: [606359](https://www.omim.org/entry/606359)
; Ensembl ID
: [ENSG00000134245](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000134245)
; UniProt ID
[P56704](https://www.uniprot.org/uniprotkb/P56704)
; Associated Diseases
: Alzheimer's Disease, Parkinson's Disease, Autism, Vertebral Defects

Overview

The WNT3A gene (WNT family member 3A) encodes a highly conserved secreted signaling protein that plays fundamental roles in embryonic development, tissue patterning, and adult tissue homeostasis. WNT3A is one of the most studied Wnt ligands due to its potent signaling activity and critical importance in development [@wodarz1998]. In the nervous system, WNT3A is essential for neural tube formation, dorsal-ventral patterning, neuronal differentiation, and synapse formation. WNT3A has been strongly implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, and neurodevelopmental disorders [@de2003][@zhang2008].

Gene Structure

The WNT3A gene is located on chromosome 17q21.31 and encodes a 352-amino acid secreted protein. The gene shares structural features with other Wnt family members, including conservation of cysteine residues critical for protein folding and function.

Genomic Organization

• Chromosome: 17q21.31
• Exons: 4
• Coding sequence: 352 amino acids
• Molecular weight: ~36 kDa

Molecular Function

Signaling Pathways

WNT3A activates multiple downstream pathways:

Canonical Wnt/β-Catenin Pathway

WNT3A is a potent activator of canonical signaling:

Key targets:

• CCND1 (cyclin D1)
• MYC
• AXIN2
• Neurogenins

Non-Canonical Pathways

• PCP pathway: RHOA, RAC, CDC42
• WNT/Ca²⁺ pathway: Calcium signaling

Receptor Binding

WNT3A binds multiple receptors:

Expression Pattern

Brain Expression

WNT3A shows distinctive expression:

Temporal Expression

• Embryonic: High expression, developmental patterning
• Postnatal: Declines in most regions
• Adult: Low but detectable in hippocampus

Role in Neural Development

Neural Tube Patterning

WNT3A is crucial for dorsal-ventral patterning:

• Dorsal specification: Promotes dorsal cell fates
• Ventral inhibition: Antagonizes SHH signaling
• Boundary establishment: Creates morphogen gradients
• Neural crest: Induction at border regions

Neurogenesis

WNT3A promotes neuronal differentiation:

• Progenitor proliferation: Initial expansion
• Neuronal commitment: Proneural gene activation
• Migration: Cortical neuron positioning
• Differentiation: Final specification

Synaptogenesis

WNT3A regulates synapse formation:

• Excitatory synapses: Promotes formation
• Synaptic plasticity: Modulates [LTP](/mechanisms/long-term-potentiation)
• Spine morphology: Controls [dendritic spines](/cell-types/dendritic-spines)
• Synaptic proteins: Regulates PSD-95, SYNAPSIN

Disease Associations

Alzheimer's Disease

WNT3A in AD [@de2003]:

Pathogenic Mechanisms:

• Reduced WNT3A signaling in AD brain
• [Aβ](/proteins/amyloid-beta) inhibits WNT3A signaling
• Restoring WNT3A reduces pathology

• WNT3A protein delivery
• Gene therapy approaches
• Small molecule activators

Parkinson's Disease

WNT3A in PD [@zhang2008]:

• Protects dopaminergic [neurons](/entities/neurons)
• Promotes neuronal survival
• May regenerate neurons

Autism Spectrum Disorder

• WNT3A polymorphisms associated
• Synaptic formation deficits
• Circuit development alterations

Vertebral Defects

WNT3A mutations cause:

• Vertebral malformations
• Caudal regression syndrome
• Limb bud defects

Therapeutic Targeting

Approaches

Clinical Potential

• Neurodegeneration protection
• Cognitive enhancement
• Regenerative therapies

Key Publications

See Also

• [Wnt Signaling Pathway](/mechanisms/wnt-signaling)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Neural Development](/mechanisms/neurodevelopment)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
• [WNT3A Protein](/proteins/wnt3a-protein)
• [LRP6](/proteins/lrp6-protein)
• [GSK3β](/entities/gsk3-beta)

Background

The study of Wnt3A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [NCBI Gene: WNT3A](https://www.ncbi.nlm.nih.gov/gene/89780)
• [UniProt: WNT3A](https://www.uniprot.org/uniprotkb/P56704)
• [Ensembl: WNT3A](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000134245)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving WNT3A Gene discovered through SciDEX knowledge graph analysis: